AI assistant
Mabpharm Limited — Governance Information 2025
Oct 31, 2025
50428_rns_2025-10-31_d5881e1e-35d9-405f-ae1e-c8fb881d8be5.pdf
Governance Information
Open in viewerOpens in your device viewer
- 1 -

邁博藥業
Mabpharm Limited
迈博药业有限公司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 2181)
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
The members of the board (the "Board") of directors (the "Director(s)") of Mabpharm Limited (the "Company") are set out below:
Executive Directors
Dr. Wang Hao (Chief Executive Officer)
Mr. Li Yunfeng
Mr. Tao Jing
Dr. Hou Sheng
Dr. Qian Weizhu
Non-executive Directors
Mr. Jiao Shuge (Chairman)
Mr. Cen Jialin
Independent Non-executive Directors
Dr. Zhang Yanyun (Lead Independent Non-executive Director)
Mr. Guo Liangzhong
Mr. Leung, Louis Ho Ming
Dr. Tao Qian
The Board has set up three committees with defined terms of reference. The membership information of these committees is set out below:
Audit Committee
Mr. Leung, Louis Ho Ming (Chairman)
Mr. Jiao Shuge
Mr. Guo Liangzhong
Remuneration Committee
Dr. Zhang Yanyun (Chairman)
Dr. Wang Hao
Mr. Guo Liangzhong
Nomination Committee
Mr. Guo Liangzhong (Chairman)
Dr. Qian Weizhu
Dr. Zhang Yanyun
Hong Kong, October 31, 2025
- 2 -